Please cite the "UC Davis/NIH NeuroMab Facility" as the source of NeuroMabs. Also, please include the complete clone number (e.g., N52A/42) to avoid ambiguity.

Use "Search Catalog" box above to search for NeuroMabs by clone number, target name or accession number.

Note that there are many ongoing NeuroMab projects so please check back frequently for new NeuroMabs and the most up-to-date information on them, including Production and QC status and newly released catalog #'s.

You can also subscribe to our mailing list to receive notifications when new NeuroMabs are added to our catalog.

If a current NeuroMab is limited in its use (e.g., you would like to have another NeuroMab for the same target but with a different isotype to enable immunofluorescent multilabelling with isotype-specific secondary antibodies), then please let us know.  We have alternate clones in reserve for many projects that could be made available for testing and/or distribution if there is sufficient interest in them.

“Validation in progress”: these NeuroMabs have not yet met our highest testing standards for some reason (e.g., unable to do target-relevant 'diagnostic' assay in-house).  However, we would still like to make them available to users on a limited basis as TC supes with the aim of getting feedback as to whether they would benefit research and should be put forward for larger-scale production and IgG purification.  So, if you test a "Validation in progress" NeuroMab, please let us know how it worked and send us data.

Validation status columns (in progress, see data sheets for specific details and examples):

Note that all NeuroMabs have tested positive by ELISA versus the synthetic peptide or recombinant protein immunogen (and in the case of modification-specific NeuroMabs, to the modified and not unmodified synthetic peptide immunogen).

T: specific reaction to transfected cells expressing target (by immunofluorescence staining and/or immunoblot)
Br-IB: single immunoreactive band of expected molecular characteristics on brain immunoblots
Br-IHC: expected immunoperoxidase-diaminobenzidine/immunofluorescence staining pattern on brain sections
KO: knockout validated in mouse brain (by immunoblot and/or immunohistochemistry)

  = validation pass

= validation fail

ND = not determined

Click on a column header to re-sort table. The catalog is also available as a downloadable CSV file.

Place orders for NeuroMabs through our distributor Antibodies Incorporated.